Teleflex

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Teleflex and other ETFs, options, and stocks.

About TFX

Teleflex, Inc. engages in the provision of medical technology products. It operates through the following business segments: Americas, EMEA (Europe, the Middle East and Africa), Asia Pacific. 

CEO
Jason Weidman
CEOJason Weidman
Employees
15,500
Employees15,500
Headquarters
Wayne, Pennsylvania
HeadquartersWayne, Pennsylvania
Founded
1943
Founded1943
Employees
15,500
Employees15,500

TFX Key Statistics

Market cap
5.89B
Market cap5.89B
Price-Earnings ratio
-6.04
Price-Earnings ratio-6.04
Dividend yield
0.97%
Dividend yield0.97%
Average volume
693.30K
Average volume693.30K
High today
$141.85
High today$141.85
Low today
$137.00
Low today$137.00
Open price
$140.21
Open price$140.21
Volume
725.19K
Volume725.19K
52 Week high
$145.00
52 Week high$145.00
52 Week low
$100.18
52 Week low$100.18

Stock Snapshot

The current Teleflex(TFX) stock price is $139.04, with a market capitalization of 5.89B. The stock trades at a price-to-earnings (P/E) ratio of -6.04 and offers a dividend yield of 0.97%.

During the trading session on 2026-11-03, Teleflex(TFX) shares reached a daily high of $141.85 and a low of $137.00. At a current price of $139.04, the stock is +1.5% higher than the low and still -2.0% under the high.

Trading activity shows a volume of 725.19K, compared to an average daily volume of 693.3K.

The stock's 52-week range extends from a low of $100.18 to a high of $145.00.

The stock's 52-week range extends from a low of $100.18 to a high of $145.00.

TFX News

Simply Wall St 1d
Teleflex Could Be 11% Undervalued Following FDA Breakthrough Device Designation

Advertisement FDA Breakthrough Device Designation sparks fresh focus on Teleflex Teleflex (TFX) drew new attention after the FDA granted Breakthrough Device D...

Teleflex Could Be 11% Undervalued Following FDA Breakthrough Device Designation
Simply Wall St 4d
How Investors May Respond To Teleflex Stock After Breakthrough Device Status

Teleflex reported that the FDA granted Breakthrough Device Designation for its Freesolve Resorbable Magnesium Scaffold for percutaneous coronary intervention, w...

Analyst ratings

60%

of 15 ratings
Buy
40%
Hold
60%
Sell
0%

People also own

Based on the portfolios of people who own TFX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.